RxDoctor Payments DataLook up a doctor →

XIIDRA: payments to doctors

Payments that named XIIDRA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$15.3M
Providers
27,725
Transactions
164,565
Average per transaction
$93

The per-transaction average — $93 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 27,725 providers the average total is $551, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Bausch & Lomb Americas Inc.$9,922,92464.9%
Novartis$3,486,36722.8%
Shire North American Group Inc$1,871,66112.2%
← All drugs & devices